Ovarian Carcinoma Immuno-reactive Antigen domain containing protein 1 (OCIAD1) was overexpressed in BJNhem20 human embryonic stem cell line (hESC) using plasmid transfection, followed by stable cell line generation. The construct pCAG-OCIAD1 was introduced into hESCs by microporation.
Resource details
BJNhem20-OCIAD1-OV line was generated by transfection of BJNhem20 human embryonic stem cells (hESCs) with pCAG-OCIAD1 construct using microporation technique with the conditions of 1100 V, 20 ms pulse width and 2 pulses. The pCAG-OCIAD1 construct was generated by cloning OCIAD1 Open Reading Frame amplicon from amino acids 1-245 between Xho1 and Not1 sites using appropriate primers. A stable hESC line was generated after subjecting these transfected cells to puromycin selection for two weeks.
OCIAD1 overexpression was validated by immunostaining and Western blotting in three biological replicates.
Expression of pluripotent stem cell markers OCT4, SSEA3/4 and TRA1-81 has been shown by immunostaining. Differentiation of these hESC lines to all the three germ layers was demonstrated by immunostaining for different markers such as AFP (endoderm), Brachyury (mesoderm) and β-III tubulin (ectoderm). Karyotype was also checked in these cells and found to be normal.
Materials and methods

Cell culture
hESC line BJNhem20 was derived from discarded Grade III embryos and tested for pluripotency (Inamdar et al., 2009 ). This cell line has been cultured continuously for over 200 passages without acquiring any karyotypic abnormality (Venu et al., 2010) . The cell line was included in the analysis of genetic stability in the International Stem Cell Initiative project (ISCI2, 2011). Cultures of BJNhem20 and the transgenic line BJNhem20-OCIAD1-OV were maintained on mouse embryonic fibroblast feeder layers in hESC medium composed of KnockOut Dulbecco's modified Eagle medium (KO-DMEM-Life Technologies Cat no. 10829-018) supplemented with 20% KnockOut Serum replacement (KOSR-Life Technologies Cat no. 10828-028), 1% GlutaMAX (Life Technologies Cat no. 35050-061), 1% non-essential amino acids (MEM-NEAA-Life Technologies Cat no. 11140-050), 0.1% β-mercaptoethanol (Life Technologies Cat no. 21985-023) and 8 ng/ml human recombinant basic fibroblast growth factor (human bFGF-Sigma Aldrich Pvt. Ltd. Cat no. F-0291).These cells were routinely passaged by mechanical cutting of undifferentiated colonies. Ltd. Cat no. Y0503) to aid the survival of single cells. mTESR medium without ROCK inhibitor was used after 12-16 h when the cells adhered. 48 h after transfection, puromycin (0.5 μg/ml Sigma Aldrich Pvt. Ltd. P8833) was added to the transfected culture and selection was continued for 10 days. Puromycin resistant individual clones of transgenic OCIAD1 overexpressing hESCs were manually picked and passaged. BJNhem20-OCIAD1-OV cells were subsequently cultured in both feeder free conditions on Matrigel in the presence of mTESR medium and on feeders with regular hESC medium.
Embryoid body differentiation
Differentiation of embryoid bodies was carried out as described before (Inamdar et al., 2009) . Briefly, colonies grown on MEFs were mechanically cut and pieces cultured in human embryoid body media (10% FBS-Hyclone-SH30070 with β-mercaptoethanol and GlutaMAX in DMEM) on low attachment plates. These hESC aggregates were allowed to grow in suspension for 3 days after which the colonies formed embryoid body-like structures and were transferred to the tissue culture dishes pre-treated with 0.1% gelatin and allowed to attach and differentiate spontaneously till the time for harvest from day 6 onwards for immunostaining analyses.
Immunostaining
hESC and hEBs were fixed in 2% paraformaldehyde (in PBS), permeabilized with Triton-X 100 (0.1% for cells and 0.3% for EBs) and then blocked with 4% FBS for 1 h at RT (Room Temperature). Post blocking, cells were incubated with the appropriate primary antibodies overnight at 4°C, then were washed with PBS at RT and incubated with secondary antibody conjugated to either Alexa Fluor 488 or 568 for 1 h at RT (Dilution 1:400 Invitrogen). The cells were washed and stained using DAPI (1:500 in M1 buffer Invitrogen) to visualize nuclei. The images were acquired using an epifluorescence microscope (IX-81 microscope system (Olympus)) fitted with a cooled CCD camera (CoolSnap, Roper Scientific) . Primary antibodies used were against OCIAD1 (Abcam Ab91574), Oct4 (BD Biosciences BD 611203), TRA1-81 and SSEA4 monoclonal antibodies were a kind gift from Peter Andrews (University of Sheffield, UK), Brachyury (Santa Cruz Biotech Cat no. SC-17743), β-III tubulin, AFP (Sigma Chemical Pvt. Ltd. Cat no. A8452).
3.5. RNA isolation/cDNA synthesis and PCR Total RNA was extracted from cells by TRIzol reagent (Life Technologies Cat no. 15596-026) following the manufacturer's instructions. 2 μg of DNase treated RNA was converted to cDNA by performing reverse transcription using Superscript II (Life Technologies Cat no. 18064-014). Primer sequences used for cDNA amplification (5′-3′) were the following: 
